Natural inhibitors of tumour necrosis factor-α production, secretion and function

被引:40
|
作者
Habtemariam, S [1 ]
机构
[1] Univ Greenwich, Sch Chem & Life Sci, London SE18 6PF, England
关键词
TNF; natural inhibitors; adhesion molecules; NF-kappa B; cAMP; inflammation; cytotoxicity;
D O I
10.1055/s-2000-8660
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Tumour necrosis factor-alpha (TNF), originally discovered by its antitumor activity, is one of the most pleotropic cytokines acting as a host defence factor in immunologic and inflammatory responses. Although the antitumour activity and mediation of inflammation by TNF could be beneficial to the host, unregulated TNF is now known to be the basis for development of various diseases including septic shock, the wasting disease, cachexia, and various inflammatory and/or autoimmune diseases. With an attempt to find potential therapeutic agents for TNF-mediated diseases, research during the last decade has led in the identification of well over one hundred natural inhibitors of either TNF production/secretion or function. This review summarises the structures, mechanism of action and therapeutic potential of these natural products.
引用
收藏
页码:303 / 313
页数:11
相关论文
共 50 条
  • [21] Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific
    Pantelidis, P
    McGrath, DS
    Southcott, AM
    Black, CM
    du Bois, RM
    RESPIRATORY RESEARCH, 2001, 2 (06): : 365 - 372
  • [22] Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific
    Panos Pantelidis
    Deirdre S McGrath
    Anne Marie Southcott
    Carol M Black
    Roland M du Bois
    Respiratory Research, 2
  • [24] Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor-α inhibitors
    Balaguer-Franch, I.
    Hernandez de la Torre-Ruiz, E.
    Lacasta-Plasin, C.
    Garcia-Piqueras, P.
    Menchen-Viso, L.
    Baniandres-Rodriguez, O.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (02) : 453 - 455
  • [25] Genetic markers of treatment response to tumour necrosis factor-α inhibitors in the treatment of psoriasis
    Ryan, C.
    Kelleher, J.
    Fagan, M. F.
    Rogers, S.
    Collins, P.
    Barker, J. N. W. N.
    Allen, M.
    Hagan, R.
    Renfro, L.
    Kirby, B.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (04) : 519 - 524
  • [26] Perforating folliculitis associated with tumour necrosis factor-α inhibitors administered for rheumatoid arthritis
    Gilaberte, Y.
    Coscojuela, C.
    Vazquez, C.
    Rosello, R.
    Vera, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) : 368 - 371
  • [27] Inhibition of tumour necrosis factor-α secretion from rat astrocytes by Sesim-Tang
    Kim, HM
    Shin, HY
    Lee, SP
    Ryu, ST
    Shin, TY
    Chae, HJ
    Kim, HR
    Lyu, YS
    Lim, KS
    PHYTOTHERAPY RESEARCH, 2002, 16 (01) : 28 - 32
  • [28] FK506 inhibits tumour necrosis factor-α secretion in human keratinocytes via regulation of nuclear factor-κB
    Lan, CCE
    Yu, HS
    Wu, CS
    Kuo, HY
    Chai, CY
    Chen, GS
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (04) : 725 - 732
  • [29] Tumour necrosis factor-α production in human alveolar macrophages:: modulation by inhaled corticosteroid
    Marshall, BG
    Wangoo, A
    Harrison, LI
    Young, DB
    Shaw, RJ
    EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (04) : 764 - 770
  • [30] Effects of extracellular pH on tumour necrosis factor-α production by resident alveolar macrophages
    Heming, TA
    Davé, SK
    Tuazon, DM
    Chopra, AK
    Peterson, JW
    Bidani, A
    CLINICAL SCIENCE, 2001, 101 (03) : 267 - 274